Clinical trial
Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
NCT00231192 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 31, 2005
- Completion date
- August 31, 2007
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes